Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biotecan
Shanghai, Shanghai, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Biotecan operates China’s largest molecular diagnostics and medical big data network, with extensive cancer sample collection and genome sequencing capabilities. No specific clinical trial outcomes, but the company provides clinical diagnostics and precision medicine solutions actively used across over 80 centers in China.
- Therapeutic areas
- OncologyInfectious DiseasesWomen's HealthCardiovascular
- Modalities
- Molecular diagnosticsGenomic data analyticsIn vitro diagnostics
- Industry
- Molecular Diagnostics
02
Partnerships
Sinopharm GroupFudan UniversityShanghai Center for Clinical LaboratoryShanghai Zhangjiang Boston Enterprise Park (for US academic/industry partnerships)
Beyond the preview
Go deeper on Biotecan.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biotecan.